Cargando…

Cost implications of implementation of pathogen-inactivated platelets

BACKGROUND: Pathogen inactivation (PI) is a new approach to blood safety that may introduce additional costs. This study identifies costs that could be eliminated, thereby mitigating the financial impact. STUDY DESIGN AND METHODS: Cost information was obtained from five institutions on tests and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCullough, Jeffrey, Goldfinger, Dennis, Gorlin, Jed, Riley, William J, Sandhu, Harpreet, Stowell, Christopher, Ward, Dawn, Clay, Mary, Pulkrabek, Shelley, Chrebtow, Vera, Stassinopoulos, Adonis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Transfusion Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691315/ https://www.ncbi.nlm.nih.gov/pubmed/25989465 http://dx.doi.org/10.1111/trf.13149

Ejemplares similares

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

Phased implementation of pathogen‐reduced platelets in a health system facilitates increased manufacturing at the blood center
por: Allen, Elizabeth S., et al.
Publicado: (2019)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal
por: Refaai, Majed A., et al.
Publicado: (2015)

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014)

Pediatric blood transfusion practices at a regional referral hospital in Kenya
por: Nabwera, Helen M., et al.
Publicado: (2016)

The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions
por: Netelenbos, Tanja, et al.
Publicado: (2018)

Elicitation of prior probability distributions for a proposed Bayesian randomized clinical trial of whole blood for trauma resuscitation
por: Jansen, Jan O., et al.
Publicado: (2020)

Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands
por: Luken, Jessie S., et al.
Publicado: (2021)

National level adjustments to the challenges of the SARS‐CoV2 pandemic on blood banking operations
por: Matusovits, Andrea, et al.
Publicado: (2021)

Predicting organ functioning with and without blood transfusion in critically ill patients with anemia
por: Kranenburg, Floris J., et al.
Publicado: (2022)

Patterns and determinants of blood transfusion in intensive care in Sweden between 2010 and 2018: A nationwide, retrospective cohort study
por: Holmqvist, Jacob, et al.
Publicado: (2022)

Racial differences in red blood cell transfusion in hospitalized patients with anemia
por: Prochaska, Micah, et al.
Publicado: (2022)

Transfusion practice in the bleeding critically ill: An international online survey—The TRACE‐2 survey
por: de Bruin, Sanne, et al.
Publicado: (2021)

Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study
por: Rozema, Johanne, et al.
Publicado: (2021)

Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation
por: Kleinman, Steve, et al.
Publicado: (2015)

The assessment of platelet function by thromboelastometry as a point‐of‐care test to guide Intercept‐treated platelet support in hemato‐oncological patients and hematopoietic stem cell transplantation recipients
por: Leitner, Gerda C., et al.
Publicado: (2020)

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

Association between maternal haemoglobin and stillbirth: a cohort study among a multi‐ethnic population in England
por: Nair, Manisha, et al.
Publicado: (2017)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion‐induced red blood cell alloimmunisation
por: Oud, Josine A., et al.
Publicado: (2021)

International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn
por: Lieberman, Lani, et al.
Publicado: (2022)

Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022)

Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice
por: Couvidou, Adèle, et al.
Publicado: (2022)

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

Individual Variation in Growth Factor Concentrations in Platelet-rich Plasma and Its Influence on Human Mesenchymal Stem Cells
por: Cho, Hee Soon, et al.
Publicado: (2011)

Aged versus fresh autologous platelet transfusion in a two‐hit healthy volunteer model of transfusion‐related acute lung injury
por: van Baarle, Floor L. F., et al.
Publicado: (2022)

Does the evidence support the importance of high transfusion ratios of plasma and platelets to red blood cells in improving outcomes in severely injured patients: a systematic review and meta‐analyses
por: da Luz, Luis Teodoro, et al.
Publicado: (2019)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
por: Lanteri, Marion C., et al.
Publicado: (2020)

Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets
por: Marini, Irene, et al.
Publicado: (2023)

Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study
por: Tay, Jason, et al.
Publicado: (2016)

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment
por: Keil, Shawn D., et al.
Publicado: (2020)

Clinical practice of transfusion medicine
Publicado: (1996)

Hemoterapia / Alejandro Benjamín Miroli ; prol. de Vicente Federico del Giudice
por: Miroli, Alejandro Benjamín

Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital
por: Hassall, Oliver, et al.
Publicado: (2009)

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen– and antibody to hepatitis B core antigen–positive donor
por: Blaich, Annette, et al.
Publicado: (2012)

Past and present of hepatitis E in the Netherlands
por: Hogema, Boris M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eaq1s8vjn6n58h2m7jsbh1ber9